ArticlePloS one2025
Investigating the mechanism of oridonin against triple-negative breast cancer based on network pharmacology and molecular docking.
Yuan Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it